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We tested the hypothesis that leukocyte telomere length (LTL) is associated with birth weight in both
extremes of abnormal fetal growth: small (SGA) and large for gestational age newborns (LGA). Clinical and
laboratory variables of the mothers and the neonates were explored; 45 newborns with appropriate weight
for gestational age (AGA), 12 SGA and 12 LGA were included. Whether the differences might be explained
by variation in OBFC1 (rs9419958) and CTC1 (rs3027234) genes associated with LTL was determined. A
significant association between birth weight and LTL was observed; LTL was significantly shorter in LGA
newborns (1.016 0.12) compared with SGA (1.736 0.19) p, 0.005, mean6 SE. Maternal (Spearman R5
20.6, p 5 0.03) and neonatal LTL (R 5 20.25, p 5 0.03) were significantly and inversely correlated with
maternal history of arterial hypertension in previous gestations. Neonatal LTL was not significantly
associated with either rs9419950 or rs3027234, suggesting that the association between neonatal LTL and
birth weight is not influenced by genetic variation in genes that modify the interindividual LTL. In
conclusion, telomere biology seems to be modulated by abnormal fetal growth; modifications in telomere
length might be programmed by an adverse environment in utero.
T
he thrifty phenotype/genotype hypothesis for explaining the origin of metabolic syndrome-associated
phenotypes was introduced several years ago. Since the first description of David Barker and coworkers
about the fetal metabolic programming of adult chronic diseases1, there has been a large amount of epide-
miological data confirming the strong association between an impaired intrauterine environment and adult
metabolic and cardiovascular diseases (CVD)2–6.
The concept of fetal programming has two important emerging putative consequences: the transmission of the
phenotype from the mother to the progeny and even through generations7, and the permanent change of the
metabolism of the newborn exposed to an adverse intrauterine environment even in the absence of the original
stimulus8. In line with the last point, all the robust epidemiological data supporting the concept of fetal program-
ming was specifically focused on birth weight and its relation with adult chronic diseases2,4,5,9.
In this regard, the most suitable hypothesis to explain the interplay between the in utero environment and the
later development of chronic diseases is the concept of epigenetic modifications10, which illustrates how the in
utero life modulates the adult phenotype and suggests the induction of permanent genomic marks. For instance,
some interesting evidence from experimental studies showed that twinning and undernutrition in the mother
around the time of conception alter the epigenetic status of genes involved in the regulation of metabolism in
hypothalamus11. Specifically, an adverse in utero environment is associated with epigenetic changes in the
methylation status of proopiomelanocortin and the glucocorticoid receptor (GR) that might have an impact
on the regulation of food intake in offspring when they reach adulthood, leading to the development of obesity11.
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In line with these data, Lillycrop and coworkers showed that feed-
ing a protein-restricted diet to pregnant rats causes hypomethylation
of GR in umbilical cord and a reduced Dnmt1 expression12.
Moreover, we demonstrated that maternal diet during pregnancy
has an impact on fetal metabolic programming through changes in
liver mitochondrial DNA content and liver transcriptional activity of
the peroxisome proliferator-activated receptor gamma, coactivator
(Ppargc1a)13.
Furthermore, evidence from human studies examining changes in
the global methylation status of cord blood DNA identified differ-
ential methylation at 19 cytosine-guanine dinucleotides associated
with either decreased or increased birth weight14. We also reported
that changes in methylation of genes related with mitochondrial
biogenesis such as PPARGC1A is associated with small and large in
comparison with normal for gestational age15. Finally, remarkable
findings about offspring exposed to gestational diabetes mellitus
support the concept of fetal programming of adult metabolic
diseases16.
Recent evidence suggests that telomere biology is potentially
plausible of modification during fetal life17, and modifications in
telomere length might be thus programmed by an adverse envir-
onment in utero18.
For instance, a recent study showed that maternal estradiol con-
centration during early pregnancy might modulate telomere length
of their infants19. In addition, Toutain et al. showed that placental
telomere length in ongoing pregnancies is associated with intrau-
terine growth restriction secondary to placental insufficiency20.
Moreover, it was shown that maternal psychological stress during
pregnancymight exert a programming effect on the telomere biology
system that directly impact on the newborn telomere length21. The
putative mechanisms associated with telomere homeostasis during
the intrauterine life and its impact on adult disease was comprehens-
ive reviewed by Entringer and colleagues earlier21.
Nevertheless, current data are still inconclusive, as previous work
showed that leukocyte telomere length (LTL) is notmuch different in
small for gestational babies (SGA) as compared with that in those
who are appropriate for gestational age (AGA)22. Thus, whether
differences exist in the two extremes of fetal growth is still unknown.
Hence, we tested the hypothesis that LTL may be associated with
birth weight in both extremes of abnormal fetal growth: SGA and
large for gestational age newborns (LGA). We also explored the
clinical features and anthropometric and laboratory variables assoc-
iated with LTL and whether the observed differences were explained
by variation in two genes associated with LTL.
Results
Clinical features, anthropometrical variables, and laboratory findings
of the pregnant women (at the time of delivery) and the neonates
according to the offspring birth weight can be seen in Table 1. Many
features of the mother and newborn associated with birth weight are
consistent with those already described23, that is, pregestational body
mass index (BMI) of the mother is associated with neonatal sex and
gestational age-adjusted body weight. As expected, newborn leptin
correlated with neonatal sex and gestational age-adjusted body weight.
Interestingly, we observed a significant association between sex and
gestational age-adjusted birth weight and LTL (Figure 1A); LTL was
significantly shorter in the LGA newborns than in the SGA ones.
Accordingly, LTL was significantly and inversely correlated
(Spearman R: 20.21, p50.008) with newborn’s body weight Z-score
(Figure 1B). In addition, LTL was significantly and inversely assoc-
iated with other developmental characteristics of the newborns, such
as neonatal head circumference (Spearman correlation R 5 20.3 p 5
0.03). There were no sex differences in LTL among the neonates.
We also explored the LTL in the mothers and observed that there
was no statistically significant association with the newborns birth
weight (Figure 2A). Nevertheless, we found that maternal LTL was
significantly and inversely correlated with history of arterial hyper-
tension in previous pregnancies (Spearman R 5 20.6, p 5 0.03);
differences in mothers’ LTL according to history of elevated arterial
blood pressure in previous pregnancies are shown in Figure 2B.
Significant differences in mothers’ systolic and diastolic blood pres-
sure according to previous history of arterial hypertension were
observed and are shown in Supplementary Figure 1.
Neonatal LTL was also significantly and inversely correlated with
maternal history of arterial hypertension in previous pregnancies
(Spearman R 5 20.25, p 5 0.03) and significantly influenced by
the arterial blood pressure status of their mothers in current preg-
nancy (Figure 2C). These findings are not surprising because of
the association of hypertension in successive pregnancies: 33% of
mothers with previous antecedents of hypertension developed
Table 1 | Clinical features, anthropometric variables, and laboratory findings of the pregnant women and the newborns according to the
neonates’ birth weight
SGA AGA LGA P level: SGA vs AGA, SGA vs LGA, AGA vs LGA*
Number of new born 12 45 12
Birth weight adjusted for gestational age
and sex. Z score
21.840.21 0.20 6 0.12 1.67 6 0.09 0.00001, 0.00008, 0.0000001
Neonate birth weight, g 2435 6 114.5 3387.4 6 126.9 4311 6 52 0.0001, 0.0003, 0.00001
Head circumference, cm 32.3 6 0.43 34.3 6 0.4 36.1 6 0.39 0.002, 0.0002, 0.004
Neonate length, cm 46 6 0.74 48.1 6 0.78 51.8 6 0.61 0.007, 0.003, 0.003
Apgar score 8.3 6 0.36 8.14 6 0.34 9 6 0 NS, NS, NS
Gestational age, weeks 38.0 6 0.48 38.2 6 0.42 39.8 6 0.21 NS, 0.006, 0.02
Leptin, ng/mL 7.07 6 1.42 16.1 6 2.05 27.0 6 4.56 0.025, 0.0003, 0.02
Plasma homocysteine levels 10.82 6 1.6 9.26 6 0.65 8.75 6 0.70 NS, NS, NS
Clinical features andanthropometric variables of pregnantwomenat the time of delivery according to the offspring’s birthweight
Age, years 28.3 6 1.8 31.8 6 1.9 28.0 6 2.3 NS, NS, NS
Physical activity, hours/week 0.66 6 0.6 1.0 6 0.37 0.0 6 0 NS, NS, NS
Number cigarettes/day 2.5 6 1.3 2.9 6 1.3 0.91 6 0.8 NS, NS, NS
Pregestational BMI, kg/m2 21.9 6 2.2 22.9 6 0.7 26.6 6 1.5 NS, 0.03, 0.03
Body weight gain during pregnancy, Kg 12.8 6 1.4 12.0 6 1.0 15.3 6 1.0 NS, NS, NS
DABP, mmHg 70.0 6 2.65 71.7 6 1.8 72.1 6 2.2 NS, NS, NS
SABP, mmHg 115.2 6 3.0 114.1 6 1.9 115.8 6 2.68 NS, NS, NS
SGA: small for gestational age. AGA: appropriate for gestational age. LGA: large for gestational age. Results are expressed as mean 6 SE. P stands for the level of statistical significance by Mann-Whitney
test. NS: not significant.
www.nature.com/scientificreports
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hypertension in the current pregnancy against 5% in those who do
not (chi square, p , 0.02).
Neonatal LTL and gene variants. Because previous genome-wide
association studies (GWASs) have identified some single nucleotide
polymorphisms (SNPs) associated with LTL variation, such as the
rs9419958 at OBFC1 oligonucleotide/oligosaccharide-binding fold
locus24,25 and the rs3027234 at CTC1 telomere maintenance complex
locus25, we decided to explore whether these genetic variants ac-
counted for the observed differences in the neonatal LTL.
Previous reports support the selection of these loci for exploration
in our sample. For example, variation in OBFC1 showed a replicated
association with mean LTL in a large scale GWA meta-analysis of
37,684 individuals from 15 cohorts26. In addition, a large population
study on the risk of CVD showed that the rs9419958 was associated
with CVD-related death, particularly among women27. The OBFC1
gene also appears to function in a telomere-associated complex of
proteins required to protect telomeres from DNA degradation28.
Finally, functional experiments demonstrated that OBFC1 represents
a new player in the telomere interactome for telomere maintenance29.
Figure 1 | (A)—Neonatal leukocyte telomere length (LTL)/ single-copy gene (HBB, human b-globin) ratio in small for gestational age (SGA), appropriate
for gestational age (AGA) and large for gestational age (LGA) neonates. P values stands for the post hoc Newman-Keuls test after ANOVA with log-
transformed variables. (B)—Pearson correlation test of log transformed values of LTL sex and and age-adjusted neonatal birth weight. R: 20.344, p50.0046.
Figure 2 | (A)—Mother LTL/single-copy gene (HBB, human b-globin) ratio according to birth weight (small for gestational age (SGA), appropriate for
gestational age (AGA), and large for gestational age (LGA). (B)—Mother LTL/single-copy gene (HBB, human b-globin) ratio according to their
previous history of arterial hypertension. (C)—Neonatal LTL/single-copy gene (HBB, human b-globin) ratio according to the current status of maternal
blood pressure.
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 5 : 7869 | DOI: 10.1038/srep07869 3
Regarding to CTC1 gene, there is biological evidence that supports
the selection of this locus for exploration of gene variants. For
instance, this gene encodes a component of the CST complex, which
plays an essential role in protecting telomeres from degradation28.
Furthermore, CTC1may have a function in DNA metabolism30 and
in regulating telomere homeostasis25; the CST complex seems also to
play critical roles in coordinating telomerase elongation and fill-in
synthesis to complete telomere replication31.
Allelic frequencies and genotype distributions of the rs9419958
and rs3027234 were in Hardy-Weinberg equilibrium. For the ana-
lysis, we used a recessive model of inheritance because of the low
frequency of the minor allele of each SNP in our sample.
We observed that the neonatal LTL was not significantly assoc-
iated with either rs9419950 or rs3027234 (Table 2), suggesting that
the association between neonatal LTL and birth weight is not influ-
enced by genetic variation in genes that modify the interindividual
LTL (Table 2). The rs9419958 was significantly correlated with neo-
natal plasma homocysteine levels (Spearman R 5 0.26, p, 0.02 and
Table 2) and significantly and negatively correlated with the mother
systolic arterial blood pressure (Spearman R 5 20.24, p , 0.04).
To better understand these unexpected findings associated with
the gene variants, we performed a functional association analysis of
interactions pathways of OBFC1 and CTC1 genes and its relation
with arterial hypertension and homocysteine levels allowing the
exploration of disease-gene interactions. The functional analysis
showed a predicted disease-gene node around OBFC1 but not
CTC1 that integrates an interrelated meta-node composed of two
genes/proteins: 1) HNF1 homeobox a (alias TCF1)—a transcription
factor that is strongly associated with the angiotensinogen (AGT),
which is associated with hypertension, and 2) HNF4A (hepatocyte
nuclear factor 4 alpha) that is connected with the methylenetetrahy-
drofolate dehydrogenase (MTHFD1) and was predicted to modulate
homocysteine levels (Figure 3).
Discussion
In this study, we asked whether newborn telomere biology might be
modulated by abnormal fetal growth and observed that birth weight
was significantly associated with LTL. Our results show for the first
time that babies who are born large have shorter telomeres in com-
parison with small babies. Accordingly, LTL was also significantly
and inversely correlated with anthropometric variables associated
with newborn’s body size, such as head circumference. Consistent
with previous human reports, LTL of SGA babies was not signifi-
cantly different from that of AGA babies22,32, suggesting that the
molecular mechanisms behind decreased fetal growth are unrelated
to telomere biology. A note of caution clarifying that the term of SGA
is not synonymous with ‘‘intrauterine growth retardation (restric-
tion)’’ must be added3.
We might wonder about the factors that modulate the telomere
biology in larger babies with shorter telomeres. LGA and SGA babies
face many challenges during fetal life, but the reason the LGA babies
are different in terms of telomere biology remains largely unknown.
Nevertheless, telomere biology might be suggested as an underlying
mechanism connecting fetal programming and chronic adult dis-
eases33, as the telomere homeostasis is quite receptive of the in utero
environment and is also highly sensitive to inflammation, oxidative
stress, and related adverse and stressful situations33. Although homo-
cysteine levels may be one of them, we were not able to find any
significant association.
Moreover, LGA infants are well known to suffer from some com-
plications, including fetal hypoxia and hypoglycemia, which is a
consequence of mother hyperinsulinemia3. Still, whether these or
other factors might be the determining ones of the modifications
of the telomere length in LGA babies remains to be explored. In
agreement with the hypothesis of the in utero reprogramming
toward senescence, previous evidence showed higher cord blood
telomerase activity in Type 1 and gestational diabetes34.
Furthermore, when we explored whether maternal factors might
be able to modify babies’ LTL at birth, we observed that arterial
hypertension was a critical factor in the modulation of the newborn
LTL.We found that LTL at birth was significantly associated not only
with arterial blood pressure of their mothers during current preg-
nancy but also with the history of arterial hypertension in previous
pregnancies, despite the fact that most mothers who developed
hypertension in the current pregnancy were devoid of personal his-
tory of hypertension. This finding supports the notion about the
maternal disease-associated programming effect of the newborn tel-
omere length. Although this finding is expected because CVDs, such
as hypertension, are associated with short LTL35, the programming
effect of the mother’s hypertension is a novel finding and suggests
that the arterial blood pressure control is an important goal to
achieve in women during fertile age, although prospective studies
are necessary to further investigate this issue.
On the other hand, we asked whether genetic factors might influ-
ence LTL at birth and then explored two SNPs in genes associated
either with telomere biology (OBFC1) or with LTL (OBCF1 and
CTC1). Interestingly, we observed that genetic variation does not
account for LTL at birth. However, an unexpected result that needs
further confirmation, such as the significant association between the
rs9419958 and fetal plasma homocysteine levels and maternal sys-
tolic blood pressure, was observed. Functional association analysis
supports the biological plausibility of our findings; specifically, it was
shown that OBCF1 interacts with HNF4A as explained in the results
Table 2 | Biochemical, obstetrical, and perinatal characteristics in the whole population according to OBFC1 rs9419958 and CTC1
rs3027234 genotypes of the neonate
Variable
OBFC1 rs9419958 P value CTC1 rs3027234 P value
rs9419958 AA 1 AG
n 5 21
rs9419958 GG
n 5 48 -
rs3027234 AA 1 AG
n 5 21
rs3027234 GG
n 5 48 -
Neonate birth weight (gr.) 3297 6 915 3308 6 879 NS 3502 6 726.8 3269 6 935.3 NS
Birth Z score 20.000 6 0.7 0.02 6 0.55 NS 0.16 6 1.2 0.03 6 1.25 NS
Head circumference, cm 33.9 6 1.92 34.2 6 2.7 NS 34.7 6 1.99 34.0 6 1.7 NS
Neonate length, cm 47.2 6 5.2 48.6 6 3.9 NS 49.5 6 4.29 47.7 6 4.4 NS
Apgar score 8.0 6 2.4 8.4 6 1.6 NS 8.0 6 2.0 8.4 6 1.5 NS
Gestational age, weeks 38.7 6 2.33 38.2 6 2.5 NS 38.9 6 1.4 38.1 6 2.8 NS
Leptin, ng/mL 14.3 6 10.4 16.7 6 14.25 NS 16.6 6 14.0 16.5 6 13.2 NS
Plasma homocysteine levels 8.05 6 3.9 9.8 6 0.16 0.03 9.7 6 4.1 9.1 6 4.0 NS
Neonate LTL 1.42 6 0.96 1.62 6 1.13 NS 1.58 6 1.44 1.57 6 0.93 NS
LTL: leukocyte telomere length. P values stand for significance using Mann Whitney t test.
www.nature.com/scientificreports
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section. Notably, a GWAS in the community-based Framingham
Heart Study on risk factors of CVD showed an association between
a variant inOBFC1 gene (the rs3814219) and flow-mediated dilation,
a surrogate of impaired endothelial function36; this variant was
among the top SNPs associated with brachial artery vascular func-
tion-related traits (p value for association 9.48 3 1027)36. These
results were replicated in a large sample of subjects from Europe,
showing that variants located in OBFC1 are associated with higher
risk of CVD, including coronary heart disease37; remarkably, higher
expression ofOBFC1 in adventitial aortic tissue was demonstrated in
this study37. Taken together, theses findings support our results and
suggest a strong biological plausibility of the association between the
OBFC1 locus and the risk of CVD in humans.
The association between the variant in OBFC1 locus and fetal
plasma homocysteine levels might represent a CVD-risk related-
associated trait in consonance with the association foundwithmater-
nal systolic blood pressure, as it was previously shown that there is a
strong linear association between the maternal and fetal levels of
homocysteine in circulation38 and that elevated homocysteine levels
are a strong and independent risk factor for vascular disease and
hypertension in adult39 and adolescents40.
Finally, we would like to discuss the putative clinical implications
of our results. Although the design of our study prevents against any
further speculation about adult health outcomes of the studied
babies, some concluding remarks might be added. For instance,
although long-term consequences of abnormal fetal growth are
already known, specifically those related with LGA infants who are
at increased risk of obesity, type 2 diabetes, and CVD in adolescence
and adulthood3, some novel data emerged. Our findings might sug-
gest a ‘‘programming senescence effect’’ of adult chronic diseases
associated with the metabolic syndrome, particularly arterial hyper-
tension. As neonatal peripheral blood LTL is shown to be highly
correlated with telomere length in tissues, we might speculate that
both abnormal fetal growth and maternal stress have an impact on
offspring telomere biology, leading to a ‘‘short-telomere phenotype’’
that renders them prone to cardiovascular complications in adult-
hood. This shorter telomere phenotype at birth indeed is imprint-
ing an accelerated aging phenotype in target tissues that might
Figure 3 | Analysis of interaction pathways of OBFC1 and CTC1 genes (pink nodes) and its relation with arterial hypertension and homocysteine
levels. The integrative analysis of biological networks was performed using ‘‘VisANT 4.0: Integrative network platform to connect genes, drugs, diseases,
and therapies’’ (a freely available and Web-based workbench at http://visant.bu.edu)47.
Table 3 | List of primer sequences used for leukocyte telomere length (LTL) and polymorphism genotyping
LTL/Genes Primer sequences Amplicon length
Telomere length F:59-CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT-39,
R:59-GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT-39
78
HBB F:59-GCTTCTGACACAACTGTGTTCACTAGC-39,
R:59-CACCAACTTCATCCACGTTCACC-39
120
CTC1 F:59-GATGGTAGTGGGATGGTGGT-39,
R:59-GAGCTACGGTGGAGAAATGC-39
188
OBFC1 F: 59-AAGGACATGACAGGGGCTTA-39,
R59-GGGCCCCAGGTCTAAAAGTA-39
194
The telomere assay amplifies a 78 bp telomeric repeat unit.
www.nature.com/scientificreports
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compromise cellular function and integrity, affecting normal physi-
ology and incrementing disease risk.
A limitation of our study should be highlighted as a larger-sized
sample and availability longitudinal clinical and biochemical mea-
surements in the infants would considerable strengthen our invest-
igation. In addition, we could have limited statistical power to detect
modest genetic effects, given the small sample size of our sample;
finally, the extrapolation of our genetic findings to other ethnicities
remains to be explored.
In conclusion, in this study, we tested the hypothesis that leuko-
cyte telomere length (LTL) may be associated with birth weight in
both extremes of abnormal fetal growth: small for gestational age and
large for gestational age newborns. Our results show that babies who
are born large have shorter telomeres in comparison with small
babies. Furthermore, when we explored whether maternal factors
might be able tomodify babies’ LTL at birth, we observed that arterial
hypertension was a critical factor in the modulation of the newborn
LTL. Our findings might suggest a ‘‘programming senescence effect’’
of adult chronic diseases associated with the metabolic syndrome,
particularly arterial hypertension.
Methods
Ethics statements. This study was performed according to the principles of the
Declaration of Helsinki and was approved by the institutional review board and the
bioethical committee of our institution. Furthermore, written consent was obtained
from all the patients.
Subjects. Sixty-nine consecutive healthy pregnant women and their babies were
included in this study, selecting around twoAGAbabies for each SGAor LGA groups.
According to the offspring birth weight normalized by sex and gestational age, there
were 45 newborns with appropriate weight for gestational age (AGA) and 24 with
abnormal weight for gestational age: 12 SGA and 12 LGA.
There were no multiple pregnancies in the study population. None of the mothers
had either preeclampsia-eclampsia or gestational diabetes or were under any med-
ication. At the time of delivery, an aliquot of cord blood was stored for further
analysis.
All the investigations performed in this study were conducted in accordance with
the guidelines of the Declaration of Helsinki. Written consent from the patients had
been granted, in accordance with the procedures approved by the ethical committee
of our institution. Complete medical, obstetrical, and perinatal data were recorded
as shown below.
Obstetric Variables. Gestational age was defined on the basis of the last menstrual
period, physical examination, and ultrasonographic biometry. Length of gestation at
delivery was measured as the number of weeks of gestation. The ultrasound measure
during the first trimester took precedence if these measures did not agree in terms of
dating gestational age at birth.
Maternity data including age, geographical origin, pregestational BMI, education,
smoking (number of cigarettes/day), history of abortion, history of preterm birth and
previous abnormal fetal weight, preeclampsia-eclampsia, hypertension in pregnancy,
hyperlipidemia or diabetes, pregnancy weight gain, weight of the previous offspring,
and gender of the newborn were evaluated. Besides, family history of disease was also
recorded.
Resting systolic and diastolic arterial blood pressure (SABP and DABP, respect-
ively) wasmeasured in all themothers after they had been sitting for at least 30 min. A
mercury sphygmomanometer was used to measure blood pressure thrice at the right
arm. Eleven mothers were diagnosed with hypertension (blood pressure equal to or
greater than 140/90 mmHg) during pregnancy, without clinical evidence of edema or
proteinuria, after 20 weeks of gestation.
Birth outcomes. Infants were classified as SGA, LGA, or AGA according to the fol-
lowing criteria: SGA was defined as birth weight for gestational age less than the
specific 10th percentile cutoff of a published Argentinian fetal growth reference41, and
LGA was defined as birth weight above the 90th percentile for gestational age and
sex3,42. The rest of the newborns were considered as AGA.
Evaluation of the newborn also included physical examination, search for any
features suggestive of a malformation syndrome, supine lengths, Apgar score evalu-
ation, and type of delivery.
Biochemical Measurements. Blood was drawn from pregnant women who were in a
supine resting position for at least 30 min and from the umbilical cord at delivery.
Routine laboratory variables were measured using standard clinical laboratory
techniques by the time of the delivery. A commercial ELISA kit was used to measure
plasma leptin concentrations (Assay Designs, Inc, U.S.A.) in blood samples collected
with sodium EDTA; concentrations of plasma total homocysteine were determined
using immunochemoluminiscence methods according to the manufacturer’s
instructions (Immulite 1000, DPC, Los Angeles, CA, USA).
DNA isolation andmeasurements of telomere length.GenomicDNAwas extracted
from white blood cells from a blood sample of the mothers and their babies using a
previously described standard method43.
An assay based on real-time quantitative PCR (iCycler thermocycler; Bio-Rad,
Hercules, CA) was used for relative LTL measurement based on a method that uses a
ratio of telomere DNA signal intensity to human b-globin single-copy gene signal
intensity44; SYBR Green was used as a fluorescent dye (Invitrogen, Buenos Aires,
Argentina).
All samples for both the telomere and single-copy gene (HBB, human b-globin)
reactions were done in triplicate in the same plate, and a control DNA sample was
added to each plate to account for interassay variability. The Ct value corresponds to
the cycle number at which the fluorescence generated within a reaction well exceeds a
predefined threshold value (100 in each run). We used the software LinRegPCR45
(version 2012.0) for efficiency computation and computed the EffCt of each replicate.
We determined the mean value of the replicates for each sample and each gene. The
relative T/S ratio is the ratio of the telomere to HBB in one sample, set in relation to
the same ratio in the control DNA. The formula for calculation of the relative T/S
ratios can be stated as follows: T/S ratio 5 [Eff telomere (control)Ct telomere (control)/
Eff telomere (sample)Ct telomere (sample)]/[Eff HBB (control)Ct HBB (control)/
Eff HBB (sample)Ct HBB (sample)]46. Specificity of amplification and absence of primer
dimers were confirmed by melting curve analysis at the end of each run. Primer
sequences and resulting PCR product lengths are shown in Table 3.
The PCR efficiencies for telomere and HBB amplification were 1.76 and 1.95 on
average. As individual samples were analyzed in triplicate and accepted only if the
standard deviation of the Ct values was ,1 Ct, the inter- and intra- experimental
coefficient of variation of the qPCR was less than 8% and 3%, respectively.
Polymorphism genotyping. Two SNPs (rs9419958 at 10: 105675945 in OBFC1 and
rs3027234 at 17: 8136092 in CTC1) were analyzed in the neonatal sample. Genotypes
of these genetic polymorphisms were examined using PCR-based restriction frag-
ment length polymorphism (RFLP); primers used in PCR-RFLP for amplifying
genomic DNA are shown in Table 3. The restriction digestion of rs9419958 and
rs3027234 and PCR products was carried out with restriction enzymes HpaII and
DdeI (New England Biolabs Inc.), respectively, at 37uC for about 12 h. The digested
products were loaded and visualized on 2.5% agarose gel after staining with ethidium
bromide. Genotyping accuracy was assessed using inclusion of duplicates and
negative.
The integrative analysis of biological networks was performed by the VisANT 4.0
platform (a freely available and Web-based workbench at http://visant.bu.edu)47.
Statistical Analysis. Otherwise indicated, quantitative data were expressed as mean
6 SE, and differences between groups were assessed using ANOVA or ANCOVA.
Because some variables, particularly, the LTL/HBB ratio, do not have a normal
distribution, we assessed differences in this variable using Mann-Whitney
nonparametric test, or post hoc Newman-Keuls after ANOVA or ANCOVA, after a
Log transformation if applicable. Correlation between two variables was performed
using Spearman rank correlation or Pearson tests. To perform these analyses, we used
the CSS/Statistica program package, StatSoft V 6.0 (Tulsa, USA).
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